Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study
Open Access
- 16 December 2017
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 17 (1) , 537
Abstract
The standardized maritime pine bark extract (Pycnogenol®) has previously shown symptom alleviating effects in patients suffering from moderate forms of knee osteoarthritis (OA). The cellular mechanisms for this positive impact are so far unknown. The purpose of the present randomized pilot controlled study was to span the knowledge gap between the reported clinical effects of Pycnogenol® and its in vivo mechanism of action in OA patients. Thirty three patients with severe OA scheduled for a knee arthroplasty either received 100 mg of Pycnogenol® twice daily or no treatment (control group) three weeks before surgery. Cartilage, synovial fluid and serum samples were collected during surgical intervention. Relative gene expression of cartilage homeostasis markers were analyzed in the patients’ chondrocytes. Inflammatory and cartilage metabolism mediators were investigated in serum and synovial fluid samples. The oral intake of Pycnogenol® downregulated the gene expression of various cartilage degradation markers in the patients’ chondrocytes, the decrease of MMP3, MMP13 and the pro-inflammatory cytokine IL1B were statistically significant (p ≤ 0.05). Additionally, protein concentrations of ADAMTS-5 in serum were reduced significantly (p ≤ 0.05) after three weeks intake of the pine bark extract. This is the first report about positive cellular effects of a dietary supplement on key catabolic and inflammatory markers in patients with severe OA. The results provide a rational basis for understanding previously reported clinical effects of Pycnogenol® on symptom scores of patients suffering from OA. ISRCTN10754119 . Retrospectively registered 08/10/2015.Keywords
Funding Information
- Horphag Research
This publication has 39 references indexed in Scilit:
- Nutraceuticals: Potential for Chondroprotection and Molecular Targeting of OsteoarthritisInternational Journal of Molecular Sciences, 2013
- Thermosensitive hydrogel made of ferulic acid-gelatin and chitosan glycerophosphateCarbohydrate Polymers, 2013
- Intersection of Inflammation and Herbal Medicine in the Treatment of OsteoarthritisCurrent Rheumatology Reports, 2012
- Proteases involved in cartilage matrix degradation in osteoarthritisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Relationship between Investigative Biomarkers and Radiographic Grading in Patients with Knee OsteoarthritisInternational Journal of Rheumatology, 2009
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Effect of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritisPhytotherapy Research, 2008
- Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo‐arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspectsPhytotherapy Research, 2008
- The burden of musculoskeletal disease—a global perspectiveClinical Rheumatology, 2006
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002